This website uses cookies to help us give you the best experience when you visit our website. By continuing to use this website, you consent to our use of these cookies.

Find out more about how we use cookies and how to manage them by reading our cookie notice.

Craig D. Wegner, PhD

Exec. Director, Translational Sciences, Emerging Innovations, Scientific Partnering & Alliances, AstraZeneca Innovative Medicines and Early Development

Dr. Wegner is a passionate translational scientist and strategic leader with over 25 years of academic and biopharmaceutical research experience. He has published peer-review manuscripts, review articles and led small initiative through to large department teams across a number of disease areas and disciplines, although originally trained in biomedical engineering – respiratory physiology and digital signal processing. Presently, Craig champions an internal Ideation Team, manages AZ’s partnership with the NIH/NCATS, and is co-lead for AstraZeneca’s expanding Open Innovation efforts of partnering internal assets (e.g., compounds) and knowhow with the disease insight and expertise of academic physician- and basic-scientists to collaboratively advance pioneering research and therapies for the benefit of patients.

You are viewing: All posts Reset filters

Our Other Authors